Annual Total Assets
$235.40 M
+$52.20 M+28.49%
April 30, 2024
Summary
- As of February 8, 2025, KALV annual total assets is $235.40 million, with the most recent change of +$52.20 million (+28.49%) on April 30, 2024.
- During the last 3 years, KALV annual total assets has fallen by -$36.61 million (-13.46%).
- KALV annual total assets is now -13.46% below its all-time high of $272.01 million, reached on April 30, 2021.
Performance
KALV Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$160.83 M
-$39.37 M-19.66%
October 31, 2024
Summary
- As of February 8, 2025, KALV quarterly total assets is $160.83 million, with the most recent change of -$39.37 million (-19.66%) on October 31, 2024.
- Over the past year, KALV quarterly total assets has dropped by -$74.57 million (-31.68%).
- KALV quarterly total assets is now -40.87% below its all-time high of $272.01 million, reached on April 30, 2021.
Performance
KALV Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
KALV Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +28.5% | -31.7% |
| 3 y3 years | -13.5% | -34.0% |
| 5 y5 years | +99.3% | +43.5% |
KALV Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -13.5% | +28.5% | -31.7% | +41.1% |
| 5 y | 5-year | -13.5% | +154.4% | -40.9% | +142.9% |
| alltime | all time | -13.5% | +3443.1% | -40.9% | +2320.7% |
KalVista Pharmaceuticals Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | - | $160.83 M(-19.7%) |
| Jul 2024 | - | $200.20 M(-15.0%) |
| Apr 2024 | $235.40 M(+28.5%) | $235.40 M(+106.6%) |
| Jan 2024 | - | $113.97 M(-17.9%) |
| Oct 2023 | - | $138.74 M(-13.5%) |
| Jul 2023 | - | $160.33 M(-12.5%) |
| Apr 2023 | $183.20 M(-10.1%) | $183.20 M(-10.0%) |
| Jan 2023 | - | $203.47 M(+25.0%) |
| Oct 2022 | - | $162.84 M(-10.7%) |
| Jul 2022 | - | $182.32 M(-10.6%) |
| Apr 2022 | - | $203.88 M(-9.4%) |
| Apr 2022 | $203.88 M(-25.0%) | - |
| Jan 2022 | - | $225.05 M(-7.7%) |
| Oct 2021 | - | $243.81 M(-5.9%) |
| Jul 2021 | - | $259.13 M(-4.7%) |
| Apr 2021 | $272.01 M(+194.0%) | $272.01 M(+310.9%) |
| Jan 2021 | - | $66.21 M(-12.2%) |
| Oct 2020 | - | $75.45 M(-10.1%) |
| Jul 2020 | - | $83.90 M(-9.3%) |
| Apr 2020 | $92.53 M | $92.53 M(-10.1%) |
| Jan 2020 | - | $102.94 M(-8.1%) |
| Oct 2019 | - | $112.06 M(-6.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jul 2019 | - | $119.88 M(+1.5%) |
| Apr 2019 | $118.13 M(+92.4%) | $118.13 M(-6.6%) |
| Jan 2019 | - | $126.53 M(-4.6%) |
| Oct 2018 | - | $132.56 M(+130.1%) |
| Jul 2018 | - | $57.62 M(-6.1%) |
| Apr 2018 | $61.39 M(+78.7%) | $61.39 M(-7.9%) |
| Jan 2018 | - | $66.66 M(+91.9%) |
| Oct 2017 | - | $34.74 M(+12.9%) |
| Jul 2017 | - | $30.78 M(-10.4%) |
| Apr 2017 | $34.34 M(+38.8%) | $34.34 M(-9.7%) |
| Jan 2017 | - | $38.05 M(+6.1%) |
| Sep 2016 | - | $35.86 M(-5.6%) |
| Jun 2016 | - | $38.01 M(-23.5%) |
| Apr 2016 | $24.75 M(-56.4%) | - |
| Mar 2016 | - | $49.67 M(-12.5%) |
| Dec 2015 | $56.79 M(+754.8%) | $56.79 M(-8.5%) |
| Sep 2015 | - | $62.08 M(-8.2%) |
| Jun 2015 | - | $67.60 M(+776.5%) |
| Mar 2015 | - | $7.71 M(+16.1%) |
| Dec 2014 | $6.64 M(-34.3%) | $6.64 M(-38.8%) |
| Sep 2014 | - | $10.86 M(+7.5%) |
| Dec 2013 | $10.11 M(+18.5%) | $10.11 M |
| Dec 2012 | $8.53 M | - |
FAQ
- What is KalVista Pharmaceuticals annual total assets?
- What is the all time high annual total assets for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals annual total assets year-on-year change?
- What is KalVista Pharmaceuticals quarterly total assets?
- What is the all time high quarterly total assets for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals quarterly total assets year-on-year change?
What is KalVista Pharmaceuticals annual total assets?
The current annual total assets of KALV is $235.40 M
What is the all time high annual total assets for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high annual total assets is $272.01 M
What is KalVista Pharmaceuticals annual total assets year-on-year change?
Over the past year, KALV annual total assets has changed by +$52.20 M (+28.49%)
What is KalVista Pharmaceuticals quarterly total assets?
The current quarterly total assets of KALV is $160.83 M
What is the all time high quarterly total assets for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high quarterly total assets is $272.01 M
What is KalVista Pharmaceuticals quarterly total assets year-on-year change?
Over the past year, KALV quarterly total assets has changed by -$74.57 M (-31.68%)